Amneal Pharmaceuticals Inc (AMRX)
8.65
+0.10
(+1.17%)
USD |
NASDAQ |
Oct 04, 16:00
8.65
0.00 (0.00%)
After-Hours: 20:00
Amneal Pharmaceuticals Shareholders Equity (Annual): 19.78M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 19.78M |
| December 31, 2022 | 298.42M |
| December 31, 2021 | 360.34M |
| December 31, 2020 | 303.27M |
| Date | Value |
|---|---|
| December 31, 2019 | 232.01M |
| December 31, 2018 | 504.75M |
| December 31, 2017 | -385.74M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
19.78M
Minimum
2023
360.34M
Maximum
2021
242.76M
Average
298.42M
Median
2022
Shareholders Equity (Annual) Benchmarks
| Eli Lilly and Co | 10.77B |
| Amphastar Pharmaceuticals Inc | 639.42M |
| Nutriband Inc | 6.438M |
| NovaBay Pharmaceuticals Inc | 3.314M |
| Palatin Technologies Inc | -0.1115M |